Brainnow Medical Technology Limited

Brainnow Medical Technology Limited specializes in developing radiology DICOM image processing application software. These tools are designed to improve diagnostic accuracy and streamline workflows in medical imaging environments. The company’s focus is on software-based solutions that integrate with existing radiology systems, ensuring compatibility with DICOM standards.

Brainnow Medical Technology Limited is headquartered in the United States. This location influences its regulatory compliance framework, particularly for devices marketed in the U.S. market.

Brainnow Medical Technology Limited’s devices are included in the FDA’s 510(k) and Unique Device Identifier (UDI) registries. These registries track Class II devices that require pre-market clearance or submission of a 510(k) notification, ensuring transparency and compliance with U.S. regulatory requirements.

Brainnow Medical Technology Limited’s devices fall under FDA Class II classification. This classification applies to devices that pose moderate risk and require special controls to ensure their safety and effectiveness, such as software-based radiology tools that enhance diagnostic processes.